We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Integrated Next-Generation Sequencing and qPCR Workflow in Clinical Diagnostics
Poster

Integrated Next-Generation Sequencing and qPCR Workflow in Clinical Diagnostics

Integrated Next-Generation Sequencing and qPCR Workflow in Clinical Diagnostics
Poster

Integrated Next-Generation Sequencing and qPCR Workflow in Clinical Diagnostics

Sanger sequencing and PCR methods have been the standard molecular methods in clinical diagnostics for decades. NGS technology revolutionized the field of genomics, transcriptomics and metagenomics and is now swiftly becoming a routine method in different areas of clinical diagnostics. Vela Diagnostics developed an integrated automated multi-purpose Sentosa workflow, which consists of: 1) a robotic liquid handling system for nucleic acid extraction, PCR set-up and/or NGS library preparation (Sentosa SX101); 2) instruments for real-time PCR or template preparation and deep sequencing; 3) kits for nucleic acid extraction, real-time PCR-based tests, NGS library preparation assays and reagents for deep sequencing; 4) assay specific applications, and 5) data analysis and reporting software. Different diagnostic applications employ the same robotic platform for qPCR set-up and preparation of NGS libraries. Vela Diagnostics offers 7 NGS and more than 20 qPCR viral, microbial and oncology CE-IVD tests, which can be run on the same system. In addition, several extraction kits were developed to isolate nucleic acids from various types of clinical samples, including FFPE, whole blood, plasma/serum, swabs, sputum, stool and urine. These unique abilities of the Sentosa workflow provide complete and relevant information to aid clinical decision-making and patient management.
Advertisement